INVESTIGADORES
PIROLA Carlos Jose
artículos
Título:
Editorial: NAFLD, chronic kidney disease, and pleiotropy-Why is PNPLA3 omnipresent?
Autor/es:
PIROLA CJ; SOOKOIAN S
Revista:
ALIMENTARY PHARMACOLOGY & THERAPEUTICS.
Editorial:
WILEY-BLACKWELL PUBLISHING, INC
Referencias:
Lugar: Londres; Año: 2023 vol. 57 p. 1180 - 1182
ISSN:
0269-2813
Resumen:
Nonalcoholic fatty liver disease (NAFLD) has become the leading cause of chronic liver disease worldwide.1 Its relationship and shared disease mechanisms with metabolic syndrome components create a complex clinical scenario.2 Most importantly, the crosstalk and bidirectional communication between the liver and other organs in regulating systemic metabolism and body homeostasis has dramatically changed the management and therapeutic approaches of patients with NAFLD.
